S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
OTCMKTS:WUXAY

WuXi AppTec (WUXAY) Stock Price, News & Analysis

$4.29
-0.23 (-5.09%)
(As of 04/19/2024 ET)
Today's Range
$4.20
$4.30
50-Day Range
$4.10
$6.92
52-Week Range
$4.10
$13.02
Volume
1,268 shs
Average Volume
15,618 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
WUXAY stock logo

About WuXi AppTec Stock (OTCMKTS:WUXAY)

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

WUXAY Stock Price History

WUXAY Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
WuXi AppTec Co. Ltd. ADR
See More Headlines
Receive WUXAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:WUXAY
CIK
N/A
Fax
N/A
Employees
41,116
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Ge Li Ph.D. (Age 57)
    Co-Founder, Chairman, President & CEO
  • Dr. Minzhang Chen Ph.D. (Age 55)
    Co-CEO & Executive Director
  • Dr. Qing Yang Ph.D. (Age 55)
    Co-CEO & Executive Director
  • Dr. Edward Hu M.B.A. (Age 62)
    Vice Chairman of the Board & Global Chief Investment Officer
  • Ms. Ming Shi (Age 50)
    Senior VP & CFO
  • Mr. Zhaohui Zhang (Age 55)
    COO of China, VP & Executive Director
  • Mr. Yuanzhou Zhang (Age 36)
    Joint Company Secretary
  • Mr. Ruijia Tang
    IR Director
  • Dr. Howard Wu J.D.
    Senior VP, General Counsel & Global Head of Human Resources
  • Dr. Jingchao Dong Ph.D.
    Senior VP & Head of RCS

WUXAY Stock Analysis - Frequently Asked Questions

How have WUXAY shares performed in 2024?

WuXi AppTec's stock was trading at $10.1450 at the start of the year. Since then, WUXAY shares have decreased by 57.7% and is now trading at $4.2912.
View the best growth stocks for 2024 here
.

Are investors shorting WuXi AppTec?

WuXi AppTec saw a increase in short interest in March. As of March 31st, there was short interest totaling 6,900 shares, an increase of 165.4% from the March 15th total of 2,600 shares. Based on an average trading volume of 16,600 shares, the days-to-cover ratio is currently 0.4 days.
View WuXi AppTec's Short Interest
.

How do I buy shares of WuXi AppTec?

Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:WUXAY) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners